Episode Details
Back to Episodes
Moderna’s mRNA Flu Shot Approved | Annapolis News
Description
Moderna’s new mRNA flu vaccine, mFLUSIVA, just got FDA approval — the first of its kind for adults 50 and up. Built on the same tech that conquered COVID, it’s designed to keep you from getting seriously sick, not necessarily stopping every flu bug. A massive trial with 40,000 people showed 27% fewer flu cases, with mild side effects like sore arm or fatigue. Rolling out this fall, it could be a game-changer for seniors and high-risk folks — and may soon hit Canada and Australia too.
Listen in comfort:
Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN:
advertise@thednn.ai
This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.
View sources & latest updates:
https://sources.thednn.ai/3571b56e4a298dcf